Peter Keng

1.8k citations

36 papers · 1.4k indexed · h-index 22

Impact in

Cancer Research top 10%
- NF-κB Signaling Pathways
Oncology top 10%
- Bone health and treatments
- Cancer Cells and Metastasis

Papers in ⓘ

Cancer Research 8
- Carcinogens and Genotoxicity Assessment 3
Oncology 14
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 3
- PARP inhibition in cancer therapy 3

Co-authors: Yuhchyau Chen (9 shared papers)Richard P. Phipps (3 shared papers)David P. Penney (3 shared papers)Brendan F. Boyce (2 shared papers)Lianping Xing (2 shared papers)Ying Tsai (6 shared papers)Stephen Derdak (2 shared papers)Paul Okunieff (6 shared papers)
Journals: International Journal of Radiation Oncology*Biology*Physics (3 papers)Advances in experimental medicine and biology (3 papers)Radiation Research (3 papers)Cancer Research (2 papers)Oncotarget (2 papers)
Partner nations: United States China Taiwan

In The Last Decade

Peter Keng

36 papers receiving 1.4k citations

Peers

Countries citing papers authored by Peter Keng

Since Specialization

Citations

This map shows the geographic impact of Peter Keng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Keng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Keng more than expected).

Fields of papers citing papers by Peter Keng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Keng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Keng. The network helps show where Peter Keng may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Keng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Keng Line = papers co-authored together Peter Keng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Tumor Necrosis Factor-α Increases Circulating Osteoclast Precursor Numbers by Promoting Their Proliferation and Differentiation in the Bone Marrow through Up-regulation of c-Fms Expression Journal of Biological Chemistry ·Zhenqiang Yao, Ping Li, Qian Zhang, Edward M. Schwarz, Peter Keng, Arnaldo Arbini, Brendan F. Boyce, Lianping Xing	2006	167
2	Characterization of Two Major Populations of Lung Fibroblasts: Distinguishing Morphology and Discordant Display of Thy 1 and Class II MHC American Journal of Respiratory Cell and Molecular Biology ·Richard P. Phipps, David P. Penney, Peter Keng, Helen Quill, Ann Paxhia, Stephen Derdak, Matthew Felch	1989	124
3	Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor The Journal of Experimental Medicine ·Kuang‐Hsiang Chuang, Saleh Altuwaijri, Gonghui Li, Jiann–Jyh Lai, Chin‐Yi Chu, Kuo‐Pao Lai, Hung‐Yun Lin, Jong‐Wei Hsu, Peter Keng, Ming‐Chi Wu, Chawnshang Chang	2009	119
4	Anti-Cancer Effect of Resveratrol is Associated with Induction of Apoptosis via a Mitochondrial Pathway Alignment Advances in experimental medicine and biology ·Weimin Sun, Wei Wang, Jung Kim, Peter Keng, Shanmin Yang, Hengshan Zhang, Chaomei Liu, Paul Okunieff, Lurong Zhang	2008	80
5	Antioxidants Reduce Consequences of Radiation Exposure Advances in experimental medicine and biology ·Paul Okunieff, Steven G Swarts, Peter Keng, Weimin Sun, Wei Wang, Jung Kim, Shanmin Yang, Hengshan Zhang, Chaomei Liu, Jacqueline P. Williams, Amy K. Huser, Lurong Zhang	2008	77
6	IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer Oncotarget ·Soo Ok Lee, Xiaodong Yang, Shanzhou Duan, Ying Tsai, Laura R. Strojny, Peter Keng, Yuhchyau Chen	2015	66
7	Lymphoma models for B-cell activation and tolerance Cellular Immunology ·David W. Scott, Jane S. Tuttle, Daniella Livnat, William L. Haynes, John Cogswell, Peter Keng	1985	63
8	IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and dna repair associated molecules Oncotarget ·Shanzhou Duan, Ying Tsai, Peter Keng, Yongbing Chen, Soo Ok Lee, Yuhchyau Chen	2015	61
9	Human Salivary Histatin 5 Causes Disordered Volume Regulation and Cell Cycle Arrest inCandida albicans Infection and Immunity ·Didi Baev, Xuewei S. Li, Jin Dong, Peter Keng, Mira Edgerton	2002	61
10	THY1 expression is associated with tumor suppression of human ovarian cancer Cancer Genetics and Cytogenetics ·Harindra R Abeysinghe, Qing Cao, Jia Xu, Stephen J. Pollock, Yana Veyberman, Nedra L. Guckert, Peter Keng, Nancy Wang	2003	58
11	Expression of Either NF-κB p50 or p52 in Osteoclast Precursors Is Required for IL-1-Induced Bone Resorption Journal of Bone and Mineral Research ·Lianping Xing, Louise Carlson, Beryl Story, Zhenxing Tai, Peter Keng, Ulrich Siebenlist, Brendan F. Boyce	2003	49
12	Human Checkpoint Protein hRad9 Functions as a Negative Coregulator To Repress Androgen Receptor Transactivation in Prostate Cancer Cells Molecular and Cellular Biology ·Liang Wang, Cheng–Lung Hsu, Jing Ni, Peng‐Hui Wang, Shuyuan Yeh, Peter Keng, Chawnshang Chang	2004	46
13	Expression of mPer1 and mPer2, Two Mammalian Clock Genes, in Murine Bone Marrow Biochemical and Biophysical Research Communications ·Yi‐Guang Chen, Athanasios Mantalaris, Patricia Bourne, Peter Keng, Jiaqian Wu	2000	45
14	Differential expression of interleukin 1α by Thy‐1⁺ and Thy‐1⁻ lung fibroblast subpopulations: Enhancement of interleukin 1α production by tumor necrosis factor‐α European Journal of Immunology ·Richard P. Phipps, Clare M. Baecher, John G. Frelinger, David P. Penney, Peter Keng, Deborah M. Brown	1990	43
15	Enhanced Antitumor Effect of Combined Triptolide and Ionizing Radiation Clinical Cancer Research ·Wei Wang, Shanmin Yang, Ying Su, Zhenyu Xiao, Chunyou Wang, Xin‐Feng Li, Ling Lin, Bruce M. Fenton, Scott F. Paoni, Ivan Ding, Peter Keng, Paul Okunieff, Lurong Zhang	2007	43
16	Combination of Radiation and Celebrex (Celecoxib) Reduce Mammary and Lung Tumor Growth American Journal of Clinical Oncology ·Weimin Liu, Yuhchyau Chen, Wei Wang, Peter Keng, Jacob N. Finkelstein, Dongping Hu, Li Liang, Min Guo, Bruce M. Fenton, Paul Okunieff, Ivan Ding	2003	39
17	Replication of Murine Mitochondrial DNA Following Irradiation Advances in experimental medicine and biology ·Hengshan Zhang, David Maguire, Steven G Swarts, Weimin Sun, Shanmin Yang, Wei Wang, Chaomei Liu, Mei Zhang, Di Zhang, Louie Zhang, Kunzhong Zhang, Peter Keng, Lurong Zhang, Paul Okunieff	2008	31
18	Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection. PubMed ·Hatsumi Nagasawa, Peter Keng, Carl G. Maki, Yongjia Yu, John B. Little	1998	31
19	Reticulocyte and micronucleated reticulocyte responses to gamma irradiation: dose–response and time-course profiles measured by flow cytometry Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Stephen D. Dertinger, Ying Tsai, Irena Nowak, Ollivier Hyrien, Hongliang Sun, Jeffrey C. Bemis, Dorothea K. Torous, Peter Keng, James Palis, Yuhchyau Chen	2007	27
20	Suppression of tumorigenicity in human ovarian carcinoma cell line SKOV-3 by microcell-mediated transfer of chromosome 11 Cancer Genetics and Cytogenetics ·Qiag Cao, Harindra R Abeysinghe, Ohn A. Chow, Jia Xu, Hui-Lee Kaung, Chin-To Fong, Peter Keng, Richard A. Insel, Wyan-Ching Mimi Lee, J. Carl Barrett, Nancy Wang	2001	26

About Peter Keng

Peter Keng is a scholar working on Cancer Research, Oncology, Immunology, Emergency Medical Services and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (4 papers), Cancer Cells and Metastasis (3 papers), Effects of Radiation Exposure (3 papers), PARP inhibition in cancer therapy (3 papers), Radiation Therapy and Dosimetry (3 papers) and Carcinogens and Genotoxicity Assessment (3 papers). The work is most often cited by research in Cancer Research (226 citations), Oncology (403 citations), Immunology (246 citations), Geriatrics and Gerontology (42 citations) and Molecular Biology (670 citations). Peter Keng has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Yuhchyau Chen, Richard P. Phipps, David P. Penney, Brendan F. Boyce, Lianping Xing, Ying Tsai, Stephen Derdak, Paul Okunieff, Shanmin Yang and Ping Li. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Advances in experimental medicine and biology, Radiation Research, Cancer Research and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact